Prelude Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,600
Closed -$11K 1427
2019
Q4
$11K Buy
+1,600
New +$11K ﹤0.01% 1228
2018
Q4
Sell
-683
Closed -$7K 1678
2018
Q3
$7K Sell
683
-4,517
-87% -$46.3K ﹤0.01% 1233
2018
Q2
$35K Sell
5,200
-2,900
-36% -$19.5K ﹤0.01% 978
2018
Q1
$70K Buy
+8,100
New +$70K 0.01% 855